TG103
A Study of TG103 Injection in Non-diabetic Overweight or Obesity
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 3 · Completed · Enrollment 675
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| TG103 22.5 mg | Obesity or overweight | 22.5 mg | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |